FURMONERTINIB

Clinical trials for FURMONERTINIB explained in plain language.

Never miss a new study

Get alerted when new FURMONERTINIB trials appear

Sign up with your email to follow new studies for FURMONERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug shows promise for lung cancer brain metastases

Disease control Completed

This phase 2 trial tested the drug furmonertinib in 24 people with advanced non-small cell lung cancer (NSCLC) that has EGFR mutations and spread to the brain. The goal was to see how long the drug could keep brain tumors from growing. Participants took a daily pill, and research…

Matched conditions: FURMONERTINIB

Phase: PHASE2 • Sponsor: Peking Union Medical College • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC

FURMONERTINIB

Get alerted when new FURMONERTINIB trials appear

New drug shows promise for lung cancer brain metastases